<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>practice-4</title>
</head>
<body>
    <table border="1">
        <thead>
            <tr>
                <td>Company</td>
                <td>Collaborator(s)</td>
                <td>Cell Type</td>
                <td>Applications</td>
            </tr>
        </thead>
       <tbody>
        <tr> 
            <td>Advance Cell<br>Technology Inc.<br>(ACT)</td>
            <td>Orgon Health & Science<br>University(OSHU)
                <ul>
                    <li>Moorfields Eye Hosp.</li>
                    <li>UCLA/Jules Stein</li>
                    <li>Wills Eye Hospital</li>
                    <li>Aberdeen Royal Infirm.</li>
                    <li>Bascom Palmer</li>
                </ul>
            </td>
            <td>hESCs</td>
            <td>RPE cells for retinal<br> diseases, including Dry<br> AMD NCT01344993 <br>and Stargardt's<br>
                NCT01 34.5005
                NCT01 469832</td>
        </tr>
        <tr>
            <td>AstraZeneca</td>
            <td>Univ. College London (UCL)</td>
            <td>hESCs</td>
            <td>Diabetic Retinopathy</td>
        </tr>
        <tr>
            <td>Centecor/J&J<br> w/iScience<br> Interventional</td>
            <td>
                <ul>
                    <li>Retina Institute of CA</li>
                    <li>Wills Eye Hospital</li>
                </ul>
            </td>
            <td>Adult SCs <br>(CNTO 2746 <br>from umbilical<br> cord fluid)</td>
            <td>RPE cells for GA <br>(atrophic dry AMD)<br>NCT01226628</td>
        </tr>
        <tr>
            <td>Cell Cure<br>Neurosciences</td>
            <td>TEVA</td>
            <td>MESCs</td>
            <td>RPE cells for dry AMD</td>
        </tr>
        <tr>
            <td>CellSeed France<br> SARL</td>
            <td>
                FGK Clinical Reserach GmbH
                <ul>
                    <li>Universitatsklinkum, Erlangen, Germany</li>
                </ul>
            </td>
            <td>oral mucosa<br>epithelial cells</td>
            <td>CAOMECS for <br>Corneal tissue repair in<br> those with limbal cell<br>deficiencies <br>NCT01 489501</td>
        </tr>
        <tr>
            <td>Fundacion<br>Clinic per a<br> la Recerca<br> Biomedica<br> (Spain)</td>
            <td>
                <ul>
                    <li>Hospital Clinic<br> Barcelona</li>
                    <li>Instituto Univ. Barraquer</li>
                    <li>Instituto de Microcirugia Ocular</li>
                </ul>
            </td>
            <td>sclerocomeal<br>progenitor cells<br>from the<br>limbus</td>
            <td>Replacement of<br>damaged corneal cells <br>NCT01470573</td>
        </tr>
        <tr>
            <td>General Hosp of<br> the Chinese<br> People's Armed<br>Police Force<br>(China)</td>
            <td></td>
            <td>unknown</td>
            <td>Optic Nerve Atrophy<br> CHICTR-TNRC-11001<br>491</td>
        </tr>
        <tr>
            <td rowspan="2">International<br>Stem Cell Corp.<br>(ISCO)</td>
            <td></td>
            <td>hpSCs<br></td>
            <td>Corneal tissue for<br>transplantation into<br>degenerated corneas </td>
        </tr>
       
       </tbody>
       
    </table>
</body>
</html>